IRIS
DI MUZIO, NADIA GISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.227
AS - Asia 5.007
NA - Nord America 3.232
SA - Sud America 1.386
AF - Africa 140
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 15.018
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.074
RU - Federazione Russa 2.879
SG - Singapore 1.881
CN - Cina 1.483
BR - Brasile 1.137
HK - Hong Kong 641
SE - Svezia 608
IT - Italia 556
VN - Vietnam 509
RO - Romania 266
FR - Francia 255
DE - Germania 173
BD - Bangladesh 103
AR - Argentina 93
GB - Regno Unito 88
FI - Finlandia 85
ES - Italia 78
IN - India 77
CA - Canada 68
MX - Messico 60
ZA - Sudafrica 51
NL - Olanda 47
ID - Indonesia 44
EC - Ecuador 40
AT - Austria 38
CO - Colombia 37
IE - Irlanda 36
IQ - Iraq 35
TR - Turchia 35
UA - Ucraina 32
JP - Giappone 26
PY - Paraguay 25
PL - Polonia 23
UZ - Uzbekistan 21
SA - Arabia Saudita 18
MA - Marocco 17
PE - Perù 16
PK - Pakistan 16
EG - Egitto 14
KE - Kenya 14
MY - Malesia 13
TN - Tunisia 13
CL - Cile 12
PH - Filippine 12
VE - Venezuela 12
NP - Nepal 11
AU - Australia 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
IR - Iran 9
DZ - Algeria 8
UY - Uruguay 8
EU - Europa 7
LT - Lituania 7
MD - Moldavia 7
TH - Thailandia 7
TW - Taiwan 7
AZ - Azerbaigian 6
CR - Costa Rica 6
JM - Giamaica 6
KZ - Kazakistan 6
MK - Macedonia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
BO - Bolivia 4
CG - Congo 4
CH - Svizzera 4
DK - Danimarca 4
LB - Libano 4
SV - El Salvador 4
GR - Grecia 3
KR - Corea 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MN - Mongolia 2
NO - Norvegia 2
QA - Qatar 2
SC - Seychelles 2
SR - Suriname 2
UG - Uganda 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
Totale 14.999
Salva come PNG Salva come JPEG
Città #
Singapore 850
Moscow 655
Hong Kong 628
Dallas 560
Ashburn 496
San Jose 394
Shanghai 319
Hefei 244
Lauterbourg 223
Beijing 209
Lawrence 203
Princeton 201
Ho Chi Minh City 177
Milan 153
New York 144
Hanoi 128
São Paulo 89
Los Angeles 79
Helsinki 58
Munich 51
Valencia 44
Nuremberg 41
Santa Clara 40
Rome 38
Orem 35
Dublin 33
Rio de Janeiro 32
Naples 31
Boardman 30
Brooklyn 29
Belo Horizonte 27
Council Bluffs 27
Da Nang 25
Johannesburg 25
Denver 24
Chennai 23
Brasília 22
Montreal 22
Guangzhou 21
Tokyo 21
Chicago 19
Mexico City 19
Curitiba 18
Guayaquil 18
Bologna 17
Frankfurt am Main 17
Haiphong 17
Manchester 17
Tashkent 17
Amsterdam 16
Warsaw 16
Biên Hòa 15
Boston 15
Can Tho 15
London 15
Poplar 15
Washington 15
Shenzhen 14
Stockholm 14
Buffalo 13
Houston 13
Porto Alegre 13
Seattle 13
Thái Bình 13
Vienna 13
Atlanta 12
Lappeenranta 12
Phoenix 12
Pune 12
Toronto 12
Baghdad 11
Bogotá 11
Cape Town 11
Dhaka 11
Fortaleza 11
Goiânia 11
Ipatinga 11
Ankara 10
Campinas 10
Charlotte 10
Genoa 10
Manaus 10
Osasco 10
Quito 10
Salvador 10
The Dalles 10
Amman 9
Duque de Caxias 9
Hangzhou 9
Juiz de Fora 9
Lima 9
Mumbai 9
Nairobi 9
Querétaro 9
Tianjin 9
Turku 9
Medellín 8
San Francisco 8
West Jordan 8
Bari 7
Totale 7.186
Salva come PNG Salva come JPEG
Nome #
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer 334
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 222
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 201
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 180
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 165
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats 159
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 155
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 143
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 138
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 136
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 131
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 128
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 121
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 121
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer 120
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 119
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 117
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 117
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study 116
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 114
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 113
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 111
A Case of Radiotherapy During Pregnancy for Oropharyngeal Cancer: Long-Term Pediatric Outcome Evaluation and Literature Review 110
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 107
Patients with Cardiac Implantable Electronic Device Undergoing Radiation Therapy: Insights from a Ten-Year Tertiary Center Experience 107
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 106
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy: Impact of time between surgery and radiotherapy 103
Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review 102
A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer 99
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 96
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 96
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 95
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers 94
Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy 92
Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 91
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 85
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 84
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 83
La qualità della vita del paziente col tumore alla prostata sottoposto a trattamento radioterapico: uno studio prospettico 81
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 81
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 80
Ocular leukemic mass-like relapse treated with CyberKnife stereotactic radiosurgery 78
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 77
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 77
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 76
Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy 74
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 74
Quality indicators in the intensity modulated/image-guided radiotherapy era 73
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration 72
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 71
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 70
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. 69
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 69
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 69
Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges 69
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience 68
Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? 67
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 67
Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy 65
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas 65
Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review 65
Knowledge-based automatic optimization of adaptive early-regression-guided VMAT for rectal cancer 65
Pros-IT CNR: an Italian prostate cancer monitoring project 65
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: A single-institute analysis of 742 patients 64
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy 64
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 64
Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters 63
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 63
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 62
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 62
Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy 61
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 61
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 61
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial 60
Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. 60
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases 60
Segmentation of FDG PET lung lesions based on a thresholding approach for BTV definition 60
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy 60
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison 60
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy 60
Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation 60
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak 60
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 60
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized? 60
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 60
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study 59
Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study 59
Characterization of volume and shape modifications of PET-positive nodes during Tomotherapy for head and neck cancer as assessed by MVCTs 59
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design 59
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients 58
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT 58
La qualità di vita del paziente con tumore alla prostata sottoposto a trattamento radioterapico 58
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy 58
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy 58
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 58
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: The impact of competing causes of mortality and patient stratification 57
Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer 57
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 57
Assessment and clinical validation of margins for adaptive simultaneous integrated boost in neo-adjuvant radiochemotherapy for rectal cancer 57
Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC 57
Totale 8.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022145 0 0 2 88 4 7 10 8 12 6 1 7
2022/20231.108 472 233 75 6 0 117 42 77 46 5 11 24
2023/2024675 11 35 59 127 46 113 22 54 18 42 53 95
2024/20253.319 431 72 53 117 105 247 680 200 548 370 212 284
2025/20269.884 707 822 939 1.391 732 236 850 636 2.507 548 313 203
Totale 15.324